SUNITINIB
sunitinib 50 mg capsule, 28
SUNITINIB (11250D)
11250D
Manner of administration:Oral
Restriction 17789
Indication: Metastatic or unresectable malignant gastrointestinal stromal tumour
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 28 | # of repeats: 1 | DPMQ: $2,019.49 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||